Elevance Health, Inc. (NYSE:ELV) Sees Significant Growth in Short Interest

Elevance Health, Inc. (NYSE:ELV - Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,850,000 shares, a growth of 6.7% from the October 15th total of 2,670,000 shares. Approximately 1.2% of the company's stock are short sold. Based on an average trading volume of 1,370,000 shares, the days-to-cover ratio is currently 2.1 days.

Elevance Health Stock Down 1.5 %

NYSE ELV traded down $6.04 during mid-day trading on Tuesday, hitting $394.66. The company's stock had a trading volume of 704,058 shares, compared to its average volume of 1,164,171. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $91.53 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 1.19 and a beta of 0.85. The company's 50 day simple moving average is $472.43 and its 200 day simple moving average is $512.56. Elevance Health has a twelve month low of $394.51 and a twelve month high of $567.26.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). The company had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The company's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the firm posted $8.99 EPS. Analysts anticipate that Elevance Health will post 32.96 earnings per share for the current year.

Elevance Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, December 5th will be issued a dividend of $1.63 per share. The ex-dividend date is Thursday, December 5th. This represents a $6.52 dividend on an annualized basis and a dividend yield of 1.65%. Elevance Health's dividend payout ratio (DPR) is 23.77%.

Wall Street Analysts Forecast Growth

ELV has been the topic of a number of research analyst reports. Morgan Stanley lowered their price target on Elevance Health from $643.00 to $551.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 23rd. UBS Group cut their price target on shares of Elevance Health from $605.00 to $555.00 and set a "buy" rating for the company in a report on Friday, October 18th. Truist Financial restated a "buy" rating and set a $520.00 target price (down from $620.00) on shares of Elevance Health in a report on Friday, October 18th. TD Cowen reduced their price objective on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a report on Monday, October 21st. Finally, Mizuho reduced their target price on Elevance Health from $585.00 to $505.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $539.20.

Insider Buying and Selling at Elevance Health

In related news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the stock in a transaction that occurred on Friday, October 18th. The shares were sold at an average price of $432.14, for a total value of $3,205,182.38. Following the transaction, the executive vice president now owns 8,423 shares in the company, valued at approximately $3,639,915.22. This represents a 46.82 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.29% of the company's stock.

Hedge Funds Weigh In On Elevance Health

A number of hedge funds have recently added to or reduced their stakes in the company. Iridian Asset Management LLC CT increased its position in shares of Elevance Health by 10.7% during the 3rd quarter. Iridian Asset Management LLC CT now owns 39,154 shares of the company's stock valued at $20,360,000 after purchasing an additional 3,786 shares during the last quarter. International Assets Investment Management LLC grew its position in shares of Elevance Health by 85,533.1% during the 3rd quarter. International Assets Investment Management LLC now owns 532,638 shares of the company's stock valued at $276,972,000 after acquiring an additional 532,016 shares during the period. Mizuho Securities USA LLC increased its stake in shares of Elevance Health by 185.4% in the 3rd quarter. Mizuho Securities USA LLC now owns 51,153 shares of the company's stock worth $26,600,000 after purchasing an additional 33,231 shares in the last quarter. abrdn plc raised its holdings in Elevance Health by 32.2% in the 3rd quarter. abrdn plc now owns 360,134 shares of the company's stock worth $186,540,000 after purchasing an additional 87,717 shares during the period. Finally, Empowered Funds LLC grew its holdings in Elevance Health by 24.9% during the third quarter. Empowered Funds LLC now owns 41,965 shares of the company's stock valued at $21,822,000 after purchasing an additional 8,379 shares during the period. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.